SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000887
Filing Date
2024-05-15
Accepted
2024-05-15 17:03:21
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snpx-20240331x10q.htm   iXBRL 10-Q 1182078
2 EX-31.1 snpx-20240331xex31d1.htm EX-31.1 8602
3 EX-31.2 snpx-20240331xex31d2.htm EX-31.2 9390
4 EX-32.1 snpx-20240331xex32d1.htm EX-32.1 5794
5 EX-32.2 snpx-20240331xex32d2.htm EX-32.2 5822
  Complete submission text file 0001410578-24-000887.txt   5405324

Data Files

Seq Description Document Type Size
6 EX-101.SCH snpx-20240331.xsd EX-101.SCH 53197
7 EX-101.CAL snpx-20240331_cal.xml EX-101.CAL 27179
8 EX-101.DEF snpx-20240331_def.xml EX-101.DEF 210968
9 EX-101.LAB snpx-20240331_lab.xml EX-101.LAB 406594
10 EX-101.PRE snpx-20240331_pre.xml EX-101.PRE 331321
63 EXTRACTED XBRL INSTANCE DOCUMENT snpx-20240331x10q_htm.xml XML 645966
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40458 | Film No.: 24952363
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)